Home
HelpTest ID AHPRU Antihypertension Panel, Random, Urine
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Container/Tube: Plastic, 5-mL tube
Specimen Volume: 4 mL
Collection Instructions:
1. Collect a random urine specimen.
2. No preservative
Reporting Name
Antihypertension Panel, Random, USpecimen Type
UrineSpecimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Urine | Refrigerated (preferred) | 14 days |
| Frozen | 14 days | |
| Ambient | 7 days |
Report Available
2 to 9 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| AHPRU | Antihypertension Panel, Random, U | 107229-7 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 621682 | Amlodipine, Random, U | 107228-9 |
| 621683 | Atenolol, Random, U | 3360-5 |
| 621684 | Bumetanide, Random, U | 3409-0 |
| 621685 | Carvedilol, Random, U | 107227-1 |
| 621686 | Chlorthalidone, Random, U | 3478-5 |
| 621687 | Clonidine, Random, U | 52960-2 |
| 621689 | Furosemide, Random, U | 3660-8 |
| 621690 | Hydralazine, Random, U | 16983-9 |
| 621691 | Hydrochlorothiazide, Random, U | 3676-4 |
| 621692 | Labetalol, Random, U | 3705-1 |
| 621693 | Lisinopril, Random, U | 107225-5 |
| 621694 | Losartan, Random, U | 107224-8 |
| 621695 | Metoprolol, Random, U | 3816-6 |
| 621696 | 7a-Thiomethylspironolactone, R, U | 12318-2 |
| 621697 | Terazosin, Random, U | 107223-0 |
| 621698 | Torsemide, Random, U | 107222-2 |
| 621688 | Interpretation, Random, U | 59462-2 |
Forms
If not ordering electronically, complete, print, and send a Renal Diagnostics Test Request (T830) with the specimen.
Useful For
Aid in the management of hypertension, especially treatment resistant hypertension
Monitoring compliance in individuals prescribed antihypertensive drug therapy
As a screen to detect non-prescribed use of common diuretics
Day(s) Performed
Thursday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
G0481
80377 (if appropriate for select payers)
Clinical Toxicology CPT Code Client Guidance
Specimen Minimum Volume
1 mL
Reference Values
Not detected: These drugs should not be present in untreated individuals.
Cutoff concentrations:
Amlodipine: 400 ng/mL
Atenolol: 800 ng/mL
Bumetanide: 40 ng/mL
Carvedilol: 40 ng/mL
Chlorthalidone: 4 ng/mL
Clonidine: 40 ng/mL
Furosemide: 4 ng/mL
Hydralazine: 400 ng/mL
Hydrochlorothiazide: 10 ng/mL
Labetalol: 40 ng/mL
Lisinopril: 1000 ng/mL
Losartan: 4 ng/mL
Metoprolol: 40 ng/mL
7-alpha-Thiomethylspironolactone: 10 ng/mL
Terazosin: 4 ng/mL
Torsemide: 40 ng/mL